|
MED8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.484000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.683420E-01 |
| Normal-vs-Stage2 |
8.751600E-01 |
| Normal-vs-Stage3 |
3.973200E-01 |
| Normal-vs-Stage4 |
7.900600E-01 |
| Stage1-vs-Stage2 |
5.556200E-01 |
| Stage1-vs-Stage3 |
1.467190E-01 |
| Stage1-vs-Stage4 |
3.996200E-01 |
| Stage2-vs-Stage3 |
4.499000E-01 |
| Stage2-vs-Stage4 |
7.595800E-01 |
| Stage3-vs-Stage4 |
7.195400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.175800E-01 |
| Normal-vs-AfricanAmerican |
5.723400E-01 |
| Normal-vs-Asian |
3.913600E-01 |
| Caucasian-vs-AfricanAmerican |
8.444400E-01 |
| Caucasian-vs-Asian |
3.582000E-01 |
| AfricanAmerican-vs-Asian |
3.467200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.812200E-01 |
| Normal-vs-Female |
6.225700E-02 |
| Male-vs-Female |
4.684100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.375400E-01 |
| Normal-vs-Extreme_Weight |
1.800360E-01 |
| Normal-vs-Obese |
8.307200E-01 |
| Normal-vs-Extreme_Obese |
6.378500E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.040200E-01 |
| Normal_Weight-vs-Obese |
9.919000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.969400E-01 |
| Extreme_Weight-vs-Obese |
3.625600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.445000E-01 |
| Obese-vs-Extreme_Obese |
2.995600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.288400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.705800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.590200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.292000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.162000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.741880E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.321900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.827790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.088100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.738400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.765000E-01 |
| Normal-VS-Type2 PRCC |
7.134000E-01 |
| Normal-VS-KIRP CIMP |
9.995700E-02 |
| Normal-VS-Unclassified PRCC |
8.373400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.179400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.754220E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.723600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.101220E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.379800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.682400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.348600E-01 |
| Normal-vs-N1 |
1.347390E-01 |
| Normal-vs-N2 |
6.805600E-01 |
| N0-vs-N1 |
1.223360E-01 |
| N0-vs-N2 |
5.383400E-01 |
| N1-vs-N2 |
7.610000E-01 |
|
|
